Hypnosis for Colectomies as Postoperative Pain Management (Hypnopal)

April 28, 2026 updated by: Somerset NHS Foundation Trust

Hypnosis for the Management of Postoperative Pain Following Colectomies: a Single Centre Randomised Controlled Feasibility Trial

The present study intends to assess the feasibility, value and direction of conducting a future, full scale randomised controlled trial, to evaluate the effects of clinical hypnosis on post-operative pain, following colectomy operations.

Pain management in the postoperative setting presents a challenge as the development and severity of pain after surgery is dependent on different patient and procedural factors. Furthermore, pain after surgery is a major concern for patients, especially when it is undermanaged. When postoperative pain control is suboptimal it delays mobilisation, reduces oral food and fluid intake after surgery, and increases the risk of developing chronic pain and other complications. These factors have a negative impact on the patient recovery process, thus increasing the length of hospital stay and healthcare costs. Hypnosis is well recognised as having an effect in pain perception, it is a brief, easy to administer intervention making it a promising non-pharmacological intervention with the potential to help postoperative pain management in patients undergoing colectomies as well as reducing anxiety and emotional stress related to surgery, while also having a positive indirect effect on recovery times, which could lead to considerable cost-savings at organisational level.

The intervention will be delivered at Somerset NHS Foundation Trust by a designated Principal Investigator. Hypnosis sessions will be given face to face in a clinical consulting room and on the ward where the participants will be admitted after surgery. The study aims to enrol 40 participants, 20 for each arm, over 12 months, from Musgrove Park Hospital who will undergo elective colectomy surgery. Eligible participants would be adults 18 years or over, undergoing elective colectomy surgery. Participants must be able to provide a written informed consent and able to understand and communicate in English.

Study Overview

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Somerset
      • Taunton, Somerset, United Kingdom, TA4 3RF
        • Somerset NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Patients will be included in the study if they meet ALL of the following inclusion criteria

  • Aged 18 years or over;
  • Undergoing elective colectomy surgery (open and laparoscopic colectomies will be included).
  • Patients that can provide written informed consent.
  • Are able to understand and communicate in English.

Exclusion Criteria:

A patient meeting ANY of the following exclusion criteria at baseline will be excluded from participation:

  • Emergency colectomies will be excluded due to the urgency of the intervention.
  • Non English speakers.
  • Patients with the following diagnosed mental health illness: personality disorders, psychosis or schizophrenia as hypnosis could aggravate these conditions.
  • Patients that are already involved in other research studies and that could influence the results of the study.
  • Any patient that is clinically unwell post-surgery with a National Early Warning Score (NEWS) of 5 or higher. NEWSscore is a tool developed for NHS England which improves the detection and response to clinical deterioration in adult patients and is a key element of patient safety and improving patient outcomes.
  • Patients with deafness or difficulty hearing as this would be essential for this therapy to be effective.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Hypnosis
Patient receives hypnosis treatment prior to surgery
The patient will receive a course of hypnosis
No Intervention: Normal care pathway
Patient will receive standard care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The effectiveness of hypnotic analgesia on post-operative pain after colectomies.
Time Frame: 365 days
The investigator is assessing the effectiveness of hypnosis on pain by using numeric pain scales to assess pain scores before and after hypnosis. This will then help the investigator evaluate pain scores between groups and compare the before and after hypnosis scores.
365 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2023

Primary Completion (Actual)

February 29, 2024

Study Completion (Actual)

April 30, 2024

Study Registration Dates

First Submitted

June 11, 2024

First Submitted That Met QC Criteria

July 8, 2024

First Posted (Actual)

July 15, 2024

Study Record Updates

Last Update Posted (Actual)

May 4, 2026

Last Update Submitted That Met QC Criteria

April 28, 2026

Last Verified

July 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypnosis

Subscribe